• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 4. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Secondary amines

Recent Advances in the Study of Thiazolo[5,4-b]pyridin-2-amine, N-ethyl- (CAS: 62638-69-1)

Thiazolo[5,4-b]pyridin-2-amine, N-ethyl- (CAS: 62638-69-1) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. Recent studies have focused on its synthesis, pharmacological properties, and mechanisms of action, particularly in the context of kinase inhibition and anti-inflammatory effects. This research brief aims to summarize the latest findings related to this compound, providing insights into its current and future applications in drug development.

The compound's unique structure, featuring a thiazolo[5,4-b]pyridine core with an N-ethylamine substituent, has been identified as a promising scaffold for the design of kinase inhibitors. Kinases play a critical role in various cellular processes, and their dysregulation is associated with numerous diseases, including cancer and inflammatory disorders. Recent research has demonstrated that Thiazolo[5,4-b]pyridin-2-amine, N-ethyl- exhibits selective inhibition against specific kinase targets, making it a valuable candidate for further optimization and development.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the synthesis and biological evaluation of Thiazolo[5,4-b]pyridin-2-amine derivatives, including the N-ethyl variant. The study employed a combination of computational modeling and in vitro assays to assess the compound's binding affinity and inhibitory activity against a panel of kinases. Results indicated that the N-ethyl substitution significantly enhanced the compound's selectivity for certain kinase isoforms, reducing off-target effects and improving its therapeutic potential.

Another recent investigation, reported in Bioorganic & Medicinal Chemistry Letters, focused on the anti-inflammatory properties of Thiazolo[5,4-b]pyridin-2-amine, N-ethyl-. The study utilized cell-based assays to evaluate the compound's ability to modulate inflammatory signaling pathways, such as NF-κB and MAPK. Findings revealed that the compound effectively suppressed the production of pro-inflammatory cytokines, suggesting its potential as a lead compound for the development of novel anti-inflammatory agents.

Despite these promising results, challenges remain in the development of Thiazolo[5,4-b]pyridin-2-amine, N-ethyl- as a therapeutic agent. Issues such as bioavailability, metabolic stability, and toxicity profiles need to be addressed through further preclinical studies. However, the compound's demonstrated selectivity and efficacy in preliminary studies underscore its potential as a valuable tool in chemical biology and drug discovery.

In conclusion, Thiazolo[5,4-b]pyridin-2-amine, N-ethyl- (CAS: 62638-69-1) represents a promising scaffold for the development of kinase inhibitors and anti-inflammatory agents. Recent research has highlighted its selective inhibition of key therapeutic targets and its potential to modulate inflammatory pathways. Continued exploration of its pharmacological properties and optimization of its chemical structure will be essential for advancing this compound toward clinical applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)